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Summary: We describe two modifications of a double-isotope assay for measuring the concentrations of
oestrogen receptors and progesterone receptors in tumour cytosols and extracts of frozen tumour sections
and endometrial sections. The concentrations of these receptors are derived from single-point/isoelectric
focussing assays after incubation of cytosols or section supernatants either with ([125I]vinyl)-nortestosterone
and [3H]oestradiol or [125I]oestradiol and [3H]ORG 2058 (16a-ethyl-21-hydroxy-19-nor[6,73H]pregn-4-ene-3,20-
dione). The concentrations of the oestrogen and progesterone receptors found in cytosols (r > 0.93) and
extracts from sections (r > 0.8) by dual label assays are highly correlated with those found by single label
assays. The method described represents an approach to the determination of oestrogen and progesterone
receptors biochemically in an amount of tissue which is comparable to that needed for immunocytochemical
procedures.
Introduction
In human breast cancer, oestrogen and progesterone
receptors represent an established determinant for
their prognosis and serve äs a guideline for their
treatment. In view of the significantly longer survival
times of patients with receptor-positive endometrial
cancer (1), oestrogen receptor and progesterone re-
ceptor determinations provide useful prognostic data.
The most frequently appüed method for the quanti-
tation öf the receptor content is the measurement of
specific high affinity binding sites after incubation of
tissue cytosols with radiolabeled receptor ligands (2,
3). During the last few years, antibodies directed
against the oestrogen receptor (4) and progesterone
receptor molecule (5) have been used either in im-
munocytochemical assays (6 — 11) or in enzyme im-
munoassays (12—14).
!) This paper was supported by the Deutsche Forschungsge-
meinschaft, Sonderforschungsbereich 232/A1.
2) Abbreviation:
PHJORG 2058 = 16a-ethyl-21-hydroxy-19-nor[6,73H]pregn-
4-ene-3,20-dione
Conventional cytosolic ligand binding assays and en-
zyme immunoassays deliver quantitative results (fmol/
mg), but at the expense of a relatively large amount
of tissue. On the other band, the immunocytochemical
assay of frozen sections provides only semiquantita-
tive scores of labelled cells, whereas enzyme immu-
noassays are expensive, especially if the number of
specimen to be tested does not fit with the number of
assays in the kit. In addition these kits have an upper
limit for a given receptor concentration of an undi-
luted cytosol.
As an alternative, for a single receptor species (15 —
17), we, like others, have recently developed an assay
for both the determination of oestrogen receptor and
progesterone receptor (18) in frozen sections of un-
fixed tumour tissue. To further minimize the amount
of tissue needed, and to determine both receptor spe-
cies quantitatively and simultaneously from the same
set of frozen sections, we describe an assay in which
sections are incubated in the presence of an iodinated
gestagenic and tritiated oestrogenic ligand and vice
versa, according to assays described for cytosols
(19-22).
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Materials and Methods
Endometrial tissue and endoraetrial carcinomas were obtained
after hysterectomy, and human breast cancer specimens were
obtained immediately after surgical removal. Samples suitable
for either homogenisation or cryostat microtomy were trimmed
of fat or necrotic tissue.
Chemicals and buffers
Radiolabelied ligands, [2,4,6,7-3H]oestradiol (85-110 Ci/mmol
= 3.1-4.1 TBq/mmol) and [3H]ORG 2058 (16<x-ethyl-21-hy-
droxy-19-nor[6,73H]pregn-4-ene-3,20-dione; 40-60 Ci/mmol
= 1.5-2.2 TBq/mmol), s well s unlabelled ORG 2058 were
purchased from Amersham (Braunschweig). [16a-125I]oestradiol
(200 Ci/mmol = 7.4 TBq/mmol) and (Z)-17a-([2-125I]vinyl)-19-
nortestosterone (200-400 Ci/mmol = 7.4-14.8 TBq/mmol)
were from NEN/DuPont (Dreieichenhain, F. R. G.). Inorganic
chemicals and oestradiol-17 were from Merck (Darmstadt),
and ampholines were from LKB (Sweden). The buffer for
hormone receptor analysis contained 10 mmol/1 NaH2PO4, 10
mmol/1 Na2MoO4 - 2H2O, 115 ml/l glycerol (87%), 1.5 mmol/1
EDTA and 10 ml/l monothioglycerol (100%); pH = 7.4.
Preparation and incubation of cytosols
After snap freezing in liquid nitrogen, tissues were pulverized
by three passag^s through a microdismembrator (Braun, Mel-
sungen) with intermediate cooling in liquid nitrogen. The tissue
powder was slurried in 5 — 10 volumes of buffer (mg + μΐ) and
centrifuged in a Kontron TGA ultracentrifuge in a TST 60.4
swing-out rotor at 144000g. The supernatant was carefully
trimmed of fat and pooled s cytosol. Protein was determined
in 10 μΐ of cytosol (23) using human serum albumin s Standard.
Cytosols (100 μΐ) were incubated for the singie label assays with
final concentrations of either 5 nmol/1 [3H]oestradiol or
[3H]ORG 2058, and for the double label assays with mixtures
of either 5 nmol/1 [3H]oestradiol and 5 nmol/1 [12SI]vinyl-
nortestosterone or 5 nmol/1 [16oc-125I]oestradiol and 5 nmol [3H]
ORG 2058. In some control experiments, a 200-fold molar
excess of either unlabeled ORG 2058 or oestradiol was added.
All test tubes were incubated for 2 h at 4 °C. After incubation,
100 μΐ supernatant were transferred to an isoelectric focussing
gel, in order to separate bound, unbound and unspecifically
bound hormone.
Preparation and incubation of sections
Duplicate sets of cryostat sections (30 μπι) to give a final section
area of about l cm2 were collected on small glass coverslips
and gently crushed into glass tubes containing 360 μΐ of the
buffer. To mimic a cytosol preparation with cryostat sections
the sections were extracted for 2 h in the hypotonic medium,
centrifuged at 800 g, the supernatants incubated and the recep-
tors separated and determined s described for cytosols. Protein
was determined in 50 μΐ supernatant (23).
Isoelectric focussing
Specifically bound, unbound and unspecifically bound fractions
of hormone were separated by isoelectric focussing of 2 mm
thick polyacrylamide gels using a horizontal electrophoresis
chamber. Each gel had a final volume of 60 ml and contained
48.5 g/l acrylamide (Merck, Darmstadt), 1.5 g/l bisacrylamide
(Merck, Darmstadt), 115 ml/l glycerol (87%), 15 ml/l ampho-
lines pH =3-10 and 10 ml/l ampholines pH =5-8 (both
LKB, Sweden). Polymerizalion was started by the addition of
180 ul of ammonium peroxodisulphate (100 g/l). The following
Solutions were used in the electrode compartments: cathode,
l mol/1 sodium hydroxide; an de, 25 mmol/1 aspartic acid and
glutamic acid.
Samples (100 μΐ) were pipetted into prefonned slots near the
cathodic electrode strip. Isoelectric fooussing was perfonned on
a cooling plate at 0°C using a multiphor Instrument (LKB,
Sweden). The gel was prefocussed until reading 100 V (30—45
min) using a constant current of 10 mA. After sample appli-
cation, the gel was focussed until reading 200V (30—60 min),
then a constant current was set at 15 mA with a limiting power
setting of 18 W to avoid heating of the gel. The focussing gel
was run until reading 1250—1300 V (approx. another 30 min).
At the end of the run the gel was fractioned manually. First
the gel was cut into sample-containing Strips. These were cut
into 3 mm pieces beginning at the alkaline side of the gel and
ending at the acidic side. These 3 min pieces were then trans-
ferred into microvials containing 4 ml Xylofluor liquid scintil-
lation Cocktail (Baker, Holland). Gel slices were extracted for
45 min at 50 °C and radioactivity was determined in a Rack-
beta liquid scintillation counter (LKB, Sweden).
Counting and evaluation
In contrast to Pollow et al. (22), we did not perfonn an external
standardisation, but used instead the auto-window-setting
mode of the beta-counter for [3H]/[125I] double label counting
(Rackbeta; LKB, Sweden). In this mode the counter defines
two energy Windows of the beta-spectrum, in which a sample
will be counted. In addition, an internal programme for auto-
matic quench compensation ensures the adaptation of the en-
ergy Windows according to the quenched amount of counts of
an external Standard superimposed on the radioactive sample.
Calculation of results
In this counting mode the counter defines the energy Windows
(channel l and 2) according to the respective beta-spectrum for
each sample individually, and according to the counts in a
channel after their adaptation by the internal quench compen-
sation. In this way the ratio of iodine counts in the low energy
part of the spectrum (channel 1) and in the high energy part
of the spectrum (channel 2) is constant and in the r nge of the
activity used, independent of the concentration of the [125I]
iodine source used (fig. 1). In addition, the tritium counts in
the high energy part of the spectrum is l % or below. Therefore,
the [125I]iodine can be quantitated directly in channel two (high
energy part of the beta-spectruni). The efficiency determined
for the total [125I]iodine activity in this channel was 30%. The
repeatedly determined ratio of [125I]iodine counts in channel l
versus those in channel 2 was 1.56. The tritium counts in the
low energy part of the spectrum were determined niathemati-
cally by programming the counter with a formula for correction
of the total counts measured in channel l:
counts/min [3H] = counts/min channel l — (1.56 χ
counts/min channel 2)
The determined counting efficiency of tritium in channel l was
67.8%.
Finally, graphs of radioactivity versus slice number were drawn
for each sample and the cumulative height of the points in a
singie peak attributable to receptor-bound hormone was meas-
ured above a diagrammatic baseline, which was introduced
with the Computer from the minimum preceeding the peak to
the minimum following the peak. This procedure gives similar
results to those obtained using a baseline determined experi-
mentally in the presence of a 200-fold molar excess of unlabelled
hormone (18). The amount of hormone whithin this peak was
calculated and the result fmally expressed in fmol/mg super-
natant protein.
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Fig. 1. Increasing amounts of a solution containing
[I25I]vinylnortestosterone (5 nmol/1) were diluted to 100
μΐ, added to 5 ml of scintillation fluid (Xylofluor, Baker,
Holland) and counted simultaneously in two channels
(—a — D — D— = Chl = low energetic part of the -
spectrum; — Δ — Δ — Δ — = Ch2 = high energy part
of the -spectrum); for further details see methods.
Results
Resolution of oestrogen receptor and proges-
terone receptor molecules
Both receptors are clearly separated from unbound
hormone and unspecifically bound hormone, deter-
mined in the presence of a 200-fold molar excess of
unlabelled hormone (18). Furthermore, after isoelec-
tric focussing and counting, both receptor peaks are
clearly resolved in a single assay, irrespectively of the
combinations of honnones used. In figure 2 the
resolution of [125I]vinylnortestosterone from [3H]oe-
stradiol (fig. 2a) and [125I]oestradiol from [3H]ORG
2058 (flg. 2b) is shown in a single piece of tissue. For
comparison, figures 2c and 2d demonstrate the recep-
tor peafcs obtained in the single label assays with
[3H]oestradiol and [3H]ORG 2058 of the same sample.
The broad shape of the oestrogen receptor peak is
not due to ineffective resolution of receptor molecules,
but due to the omission of the limited trypsination
procedure for the oestrogen receptor, to avoid diges-
tion of progesterone receptor molecules (18).
Assays with cytosols
As a first Step and s a prerequisite for the section
assay, we checked the double label assay in tumour
cytosols of human mammary carcinomas. We com-
pared the receptor tevels obtained by this assay with
receptor levels determined in the single label assay
with the same cytosol. As shown in figure 3 for the
combination [125I]vinylnortestosterone/[3H]oestradiol,
correlation coefficients of r = 0.97 (fig. 3a, n = 37,
slope = 0.877) were found for the gestagenic com-
ponents, and r = 0.93 (fig. 3b, n = 38, slope = 0.742)
for oestradiol. Using the mixture of [125I]oestradiol
and [3H]ORG 2058, the correlations were r = 0.97
(fig. 3c, n = 20, slope =0.741) for the oestrogen
receptor determinations and r = 0.88 (fig. 3d, n = 23,
slope = 1.127) for the progesterone receptor assay.
Simultaneous determinations of oestrogen
receptor and progesterone receptor in super-
natants from sections
The results described above encouraged us to perform
the assay with frozen sections of human endometrial
tissue. The results of the comparative experiments are
illustrated in figure 4. In general, we found a slightly
poorer correlation in section supernatants than
in cytosols. For the hormone combination
[125I]vinylnortestosterone/[3H]oestradiol, we found a
correlation of r = 0.81 (fig. 4a, n = 18, slope = 1.102)
for progesterone receptor, and r = 0.8 (fig. 3b, n = 21,
slope = 0.607) for oestrogen receptor determinations.
For the combination [I25I]oestradiol/[3H]ORG 2058
they were r = 0.82 (fig. 3c, n = 23, slope = 1.038) for
oestrogen receptor, and r = 0.9 (fig. 3d, n = 23, slope
= 1.032) for progesterone receptor.
In summary, the values determined with the iodine
label, which are determined directly, correlate better
than those measured with the tritiated hormone,
which in part is calculated indirectly by a mathemat-
ical transformation of data of the lower part of the
beta-energy spectrum. The exception is the determi-
nation of [3H]ORG 2058.
Discussion
We have established the double isotope assay for the
determination of steroid hormone receptors in ex-
tracts from cryostat sections. As a first Step, we
adapted double isotope methods for Simultaneous
receptor determination in cytosols (19 — 22) to a cy-
tosolic assay with isoelectric focussing for receptor
quantitation. The results were comparable to those
described in the literature (19—22). In a second Step,
this method was used in the analysis of the receptor
content in supernatants from frozen sections. During
both Steps the dual label assay was checked against
the respective single label assay performed in parallel.
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a) Resolution of [125I]vmylnortestosterone and [3H]oestradiol.
b) Resolution of [125I]oestradiol and [3H]ORG 2058.
c) and d) The corresponding single label assays with [3H]oestradiol and [3H]ORG 2058 are illustrated.
From our results we favour the combination [125I]oes-
tradiol/[3H]ORG 2058 for both the analysis of cyto-
sols and sections. This combination is to be preferred,
although, with one exception, the correlation coeffi-
cients are slightly poorer than in the
[125I]vinylnortestosterone/[3H]oestradiol experiments.
But with a single exception, the slopes of the regres-
sion lines for the plots of values from cytosolic and
section experiments shown are approximateiy unity.
For [3H]oestradiol, the slope of the regressioh line in
the parallel determination t [125I]vinylnortestosterone
was 0.661.
The advantages and disadvantages of the assay System
described here can be listed s follows.
1. The assay is less expensive than the comparative
single radiolabel assay and immunocytochemical as-
says;
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Fig. 3. Cytosol assays. Comparison of receptor concentrations obtained in single and double label experiments with cytosols.
a) Progesterone receptor measured with [I25l]vinylnortestpsterone (dual label assay) and [3H]oestradiol (single label assay).
b) Oestrogen receptor measured with [3H]oestradiol in both single and double label assay.
c) Oestrogen receptor measured with [t25I]oestradiol (double label assay) and [3H]oestradiol (single label assay).
d) Progesterone receptor measured with [3H]ORG 2058 in both single and dual label assay.
2. The amount of tissue (18) again has been further
reduced by one half. Therefore, the assay can be
performed with a quantity of tissue similar to that
used in immunocytochemieal procedures.
3. The fugal result is a quantitative rneasurement of
receptor concentrations (fmol/mg) and not a semi-
quantitative score of labelled cells.
4. The receptors are determined in the same set of
frozen sections.
5. Histological controls or histochemical localizations
of the receptors can be made in immediately neigh-
bouring serial sections.
6. The receptors are separated in a single step from
unbound and unspecifically bound hormone. The re-
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sulting peak pattern of oestrogen receptor and pro-
gesterone receptor serve s an additional quality con-
trol of the assay, and s described recently (18) recep-
tor concentrations measured by isoelectric focussing
are always higher than with the Standard dextran-
coated charcol (DCC) assay.
However, one disadvantage cannot be concealed. The
Separation step by isoelectric focussing makes this
assay more time consuming than other assays. How-
ever, this procedure is necessary to concentrate recep-
tor molecules in the rather dilute extracts of sections.
In conclusion, with respect to the amount of tissue
needed, the described assay System isfc a biochemical
alternative to immunocytochemical procedures, and
it provides concentrations of receptors s the final
result. We feel that the method is especially useful
' »
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1. when small specimens of mammary carcinomas
have to be analysed biochemically for receptor con-
tent,
2. for research projects that simultaneously seek to
determine receptor quantities and receptor localiza-
tion.
The assay is equally well applicable to cells grown in
culture, and is an important tool if the receptor con-
tent has to be determined in a small number of cells.
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